Epigenetics continues to be a burgeoning area for therapeutic intervention in oncology. This conference will bring together experts from both academia and industry to further explore epigenetic susceptibilities in cancer through the identification of novel targets and transnational medicine approaches to define biomarkers, resistance mechanisms and clinical combination strategies.
- Epigenetics in Cancer: Translational Medicine Approaches